Moscow Bets Big on Protein Therapies to Tackle Severe Diseases
The biotech process development center at Sputnik Technopolis, operated by R-Pharm Group - a resident of the Technopolis Moscow special economic zone - is working on 11 original molecules to develop new therapies for cancer and autoimmune diseases, announced Deputy Mayor Maxim Liksutov.
5News собрал это резюме из публичной ленты источника. Полная статья со всеми подробностями находится на sputniknews.com — права на контент принадлежат Sputnik News (oficial).
